95. Skyes AG, (Ed). Advances in Inorganic Chemistry: Academic Press; 1994. 96. Souris JS. Seeing the light in bone metabolism imaging. Trends Biotechnol. 2002;20(9):364-6. 97. Stokkel MPM, Olmos RAV, Hoefnagel CA, Richel DJ. Tumor and therapy associated abnormal changes on bone-scintigraphy – old and new phenomena. Clin Nucl Med. 1993;18(10):821-8. 98. Sugawara Y, Kikuchi T, Kajihara M, Semba T, Ochi T, Fujii T, et al. Thallium-201 scintigraphy in bone and soft-tissue tumors: a comparison of dynamic, early and delayed scans. Ann Nucl Med. 2005;19(6):461-8. 99. Sundrehagen E. Formation of reduced Tc-99m by concentrated hydrochloric-acid and vacuum evaporation. Int J Appl Radiat Is. 1982;33(2):89-91. 100. Vallabhajosula S, Killeen RP, Osborne JR. Altered biodistribution of radiopharmaceuticals: Role of radiochemical/pharmaceutical purity, physiological, and pharmacologic factors. Semin Nucl Med. 2010;40(4):220-41. 101. Vanaardenne YT, Winter WA, Verdegaal WP, Taconis WK. Detection of inflammatory Bowel-disease with Tc-99m DTPA. Diagn Imaging. 1980;49(6):334-8. 102. Wang TS, Fawwaz RA, Johnson LJ, Mojdehi GE, Johnson PM. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication. J Nucl Med. 1980;21(8):767-70. 103. Wang Y, Luo S, Lin J, Qiu L, Cheng W, Zhai H, et al. Animal studies of 99mTc-iPIDP: a new bone imaging agent. Appl Radiat Isot. 2011;69(9):1169-75. 104. Wellington K, Goa KL. Zoledronic acid – A review of its use in the management of bone metastases and hypercalcaemia of malignancy. Drugs. 2003;63(4):417-37. 105. Wellman HN, Schauwecker D, Robb JA, Khairi MR, Johnston CC. Skeletal scintimaging and radiography in the diagnosis and management of Paget’s disease. Clin Orthop Relat Res. 1977(127):55-62. 106. Zolle I,(Ed). Technetium – 99m Pharmaceuticals : Preparation and Quality Control in Nuclear Medicine: Springer; 2007. 107. Zuckier LS, Freeman LM. Nonosseous, nonurologic uptake on bone scintigraphy: atlas and analysis. Semin Nucl Med. 2010;40(4):242-56.
144



157. SAYFAYA BENZER SAYFALAR

tabs_sener_yagiz_191898 - Sayfa
...


157. SAYFA ICERIGI

95. Skyes AG, (Ed). Advances in Inorganic Chemistry: Academic Press; 1994. 96. Souris JS. Seeing the light in bone metabolism imaging. Trends Biotechnol. 2002;20(9):364-6. 97. Stokkel MPM, Olmos RAV, Hoefnagel CA, Richel DJ. Tumor and therapy associated abnormal changes on bone-scintigraphy – old and new phenomena. Clin Nucl Med. 1993;18(10):821-8. 98. Sugawara Y, Kikuchi T, Kajihara M, Semba T, Ochi T, Fujii T, et al. Thallium-201 scintigraphy in bone and soft-tissue tumors: a comparison of dynamic, early and delayed scans. Ann Nucl Med. 2005;19(6):461-8. 99. Sundrehagen E. Formation of reduced Tc-99m by concentrated hydrochloric-acid and vacuum evaporation. Int J Appl Radiat Is. 1982;33(2):89-91. 100. Vallabhajosula S, Killeen RP, Osborne JR. Altered biodistribution of radiopharmaceuticals: Role of radiochemical/pharmaceutical purity, physiological, and pharmacologic factors. Semin Nucl Med. 2010;40(4):220-41. 101. Vanaardenne YT, Winter WA, Verdegaal WP, Taconis WK. Detection of inflammatory Bowel-disease with Tc-99m DTPA. Diagn Imaging. 1980;49(6):334-8. 102. Wang TS, Fawwaz RA, Johnson LJ, Mojdehi GE, Johnson PM. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication. J Nucl Med. 1980;21(8):767-70. 103. Wang Y, Luo S, Lin J, Qiu L, Cheng W, Zhai H, et al. Animal studies of 99mTc-iPIDP: a new bone imaging agent. Appl Radiat Isot. 2011;69(9):1169-75. 104. Wellington K, Goa KL. Zoledronic acid – A review of its use in the management of bone metastases and hypercalcaemia of malignancy. Drugs. 2003;63(4):417-37. 105. Wellman HN, Schauwecker D, Robb JA, Khairi MR, Johnston CC. Skeletal scintimaging and radiography in the diagnosis and management of Paget’s disease. Clin Orthop Relat Res. 1977(127):55-62. 106. Zolle I,(Ed). Technetium – 99m Pharmaceuticals : Preparation and Quality Control in Nuclear Medicine: Springer; 2007. 107. Zuckier LS, Freeman LM. Nonosseous, nonurologic uptake on bone scintigraphy: atlas and analysis. Semin Nucl Med. 2010;40(4):242-56.
144




single.php